antibiotics causing adverse effects in therapeutic use
Showing 1 - 7 of 7
Antibiotics Causing Adverse Effects in Therapeutic Use Trial in Cairo (Group 1: Antibiotic receiving group)
Recruiting
- Antibiotics Causing Adverse Effects in Therapeutic Use
- Group 1: Antibiotic receiving group
-
Cairo, EgyptDepartment of Obstetrics and Gynecology, Kasr Al-Ainy University
Mar 24, 2022
Utility Assessment of a Pharmacy-to-Dose Daptomycin
Enrolling by invitation
- Antibiotics Causing Adverse Effects in Therapeutic Use
- Retroactive review of patient data of those receiving a dose of daptomycin
-
Dallas, TexasMethodist Dallas Medical Center
Feb 3, 2022
Microtia, UTI, Bacteriuria Trial (Bactrim DS 800Mg-160Mg Tablet, Placebo oral tablet)
Withdrawn
- Microtia
- +4 more
- Bactrim DS 800Mg-160Mg Tablet
- Placebo oral tablet
- (no location specified)
Oct 28, 2021
Antimicrobial Stewardship, Antibiotics Causing Adverse Effects in Therapeutic Use Trial in Australia (Antimicrobial Stewardship
Recruiting
- Antimicrobial Stewardship
- Antibiotics Causing Adverse Effects in Therapeutic Use
- Antimicrobial Stewardship ENGAGEMENT bundle
-
Eight Mile Plains, Queensland, Australia
- +3 more
Oct 5, 2021
Antibiotics Causing Adverse Effects in Therapeutic Use Trial in Boston (Chart Review)
Enrolling by invitation
- Antibiotics Causing Adverse Effects in Therapeutic Use
- Chart Review
-
Boston, MassachusettsVA Boston Healthcare System
Aug 18, 2021
Antibiotics Causing Adverse Effects in Therapeutic Use Trial in Amman (Clindamycin 300 mg, Amoxicillin with Clavulanic Acid
Not yet recruiting
- Antibiotics Causing Adverse Effects in Therapeutic Use
- Clindamycin 300 mg
- Amoxicillin with Clavulanic Acid 635mg
-
Amman, JordanThe University of Jordan Hospital
Jul 18, 2021
Antibiotics Causing Adverse Effects in Therapeutic Use Trial in West Bend (FEP-TAZ 4 g, Placebo)
Completed
- Antibiotics Causing Adverse Effects in Therapeutic Use
- FEP-TAZ 4 g
- Placebo
-
West Bend, WisconsinSpaulding Clinical Research
Aug 8, 2018